NCT02612376

Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study

Rocky Mountain Alzheimer's Disease Center at the University of Colorado School of Medicine (RMADC at UCSOM) Longitudinal Biomarker and Clinical Phenotyping Study

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 800 (estimated)
• Sponsor: University of Colorado, Denver · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This study plans to establish a large bank of blood, cerebral spinal fluid (CSF), imaging, and clinical data. These data and samples will be used for future research into the causes of Alzheimer's disease (AD), Down Syndrome (DS) and other diseases that cause thinking and memory problems. This future research will also study how treatments for these diseases work. This research may help develop new treatments for some diseases of the nervous system and help understand these diseases better.

Conditions

• Alzheimer Disease
• Down Syndrome
• Mild Cognitive Impairment

Timeline

• Start date: 2016-02-01
• Primary completion: 2025-04-01
• Completion: 2025-05-01
• First posted: 2015-11-23
• Last updated: 2025-06-03

Locations

1 site across 1 country: United States